Literature DB >> 16827590

Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study.

Sander W Zielhuis1, Johannes F W Nijsen, Gerard C Krijger, Alfred D van het Schip, Wim E Hennink.   

Abstract

The clinical application of holmium-loaded poly(L-lactic acid) (PLLA) microspheres for the radionuclide treatment of liver malignancies requires in depth understanding of the degradation characteristics of the microspheres. To this end, an in-vitro degradation study was conducted. PLLA-microspheres with and without HoAcAc loading, and before and after neutron or gamma irradiation, were incubated in a phosphate buffer at 37 degrees C for 12 months. In contrast with the other microsphere formulations, only the neutron-irradiated Ho-PLLA-MS disintegrated. At the end of the experiment (52 weeks) highly crystalline fragments, as evidenced from Differential Scanning Calorimetry, were present. Infrared spectroscopy showed that these fragments consisted of holmium lactate. In conclusion, this study demonstrates that the degradation of neutron-irradiated Ho-PLLA-MS was substantially accelerated by the HoAcAc incorporation and subsequent neutron irradiation. The degradation of these microspheres in aqueous solution resulted in the formation of insoluble holmium lactate microcrystals without release of Ho3+.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827590     DOI: 10.1021/bm060230r

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

1.  The studies on the aromaticity of fullerenes and their holmium endohedral compounds.

Authors:  Bisheng Tan; Rufang Peng; Hongbo Li; Bing Wang; Bo Jin; Shijin Chu; Xinping Long
Journal:  J Mol Model       Date:  2010-05-05       Impact factor: 1.810

2.  Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.

Authors:  Maarten L J Smits; Johannes F W Nijsen; Maurice A A J van den Bosch; Marnix G E H Lam; Maarten A D Vente; Julia E Huijbregts; Alfred D van het Schip; Mattijs Elschot; Wouter Bult; Hugo W A M de Jong; Pieter C W Meulenhoff; Bernard A Zonnenberg
Journal:  J Exp Clin Cancer Res       Date:  2010-06-15

3.  Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study.

Authors:  M A D Vente; J F W Nijsen; R de Roos; M J van Steenbergen; C N J Kaaijk; M J J Koster-Ammerlaan; P F A de Leege; W E Hennink; A D van Het Schip; G C Krijger
Journal:  Biomed Microdevices       Date:  2009-08       Impact factor: 2.838

4.  Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study.

Authors:  Wouter Bult; Hendrik de Leeuw; Olav M Steinebach; Martijn J van der Bom; Hubert Th Wolterbeek; Ron M A Heeren; Chris J G Bakker; Alfred D van Het Schip; Wim E Hennink; J Frank W Nijsen
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

Review 5.  Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.

Authors:  Oleksii O Peltek; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2019-08-21       Impact factor: 10.435

6.  Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.

Authors:  M A D Vente; J F W Nijsen; T C de Wit; J H Seppenwoolde; G C Krijger; P R Seevinck; A Huisman; B A Zonnenberg; T S G A M van den Ingh; A D van het Schip
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-11       Impact factor: 9.236

7.  Development of microspheres for biomedical applications: a review.

Authors:  Kazi M Zakir Hossain; Uresha Patel; Ifty Ahmed
Journal:  Prog Biomater       Date:  2014-12-10

Review 8.  Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres.

Authors:  C Bouvry; X Palard; J Edeline; V Ardisson; P Loyer; E Garin; N Lepareur
Journal:  Biomed Res Int       Date:  2018-12-31       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.